# Lamivudine as a Novel Clinical Effort for Rett Syndrome

> **NCT07640503** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Maria Denise Fernandes Carvalho de Andrade** · enrollment: 10 (estimated)

## Conditions studied

- Rett Syndrome

## Interventions

- **DRUG:** Lamivudine

## Key facts

- **NCT ID:** NCT07640503
- **Lead sponsor:** Maria Denise Fernandes Carvalho de Andrade
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-11-05
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07640503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07640503, "Lamivudine as a Novel Clinical Effort for Rett Syndrome". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07640503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*